Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Medigene AG to participate at BIO International in Boston | ||
By: GlobeNewswire - 30 May 2023 | Back to overview list |
|
Planegg/Martinsried, May 30, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will participate at the BIO International Convention, taking place June 5-8, 2023 in Boston, MA. BIO International Convention Date: June 5-8, 2023, Medigene’s management team will be available for one-on-one meetings at the event. Please contact Sandya von der Weid of LifeSci Advisors at svonderweid@lifesciadvisors.com to schedule a meeting. --- end of press release --- About Medigene AG About Medigene’s End-To-End Platform Medigene AG LifeSci Advisors In case you no longer wish to receive any information about Medigene, please inform us by e-mail (investor@medigene.com). We will then delete your address from our distribution list. |
||
|
||
Copyright 2023 GlobeNewswire | Back to overview list |